CD274 and melanoma: Upregulation in tumor cells can be due to constitutively active oncogenic signaling pathways (referred to as innate immune resistance); although for melanoma cell lines PD-L1 expression levels were variable and independent from any driver mutation in MAPK or PI3K pathway [11, 17].